BACKGROUND: This study aims to describe the magnitude of hospital costs among patients undergoing elective colectomy, cholecystectomy, and pancreatectomy, determine whether these costs relate as expected to duration of care, patient case-mix severity and comorbidities, and whether risk-adjusted costs vary significantly by hospital. Correctly estimating the cost of production of surgical care may help decision makers design mechanisms to improve the efficiency of surgical care. STUDY DESIGN: Patient data from 202 hospitals in the ACS-NSQIP were linked to Medicare inpatient claims.
There were 21,923 patients from 202 hospitals who underwent an elective colectomy (n ¼ 13,945), cholecystectomy (n ¼ 5,569), or pancreatectomy (n ¼ 2,409). Median cost was lowest for cholecystectomy ($15,651) and highest for pancreatectomy ($37,745). Room and board costs accounted for the largest proportion (49%) of costs and were correlated with length of stay, R ¼ 0.89, p < 0.001. The patient case-mix severity and comorbidity variables most associated with cost were American Society of Anesthesiologists (ASA) class IV (estimate 1.72, 95% CI 1.57 to 1.87) and fully dependent functional status (estimate 1.63, 95% CI 1.53 to 1.74). After risk-adjustment, 66 hospitals had significantly lower costs than the average hospital and 57 hospitals had significantly higher costs. The amount of money the US spends on health care is typically expressed as charges or costs. [1] [2] [3] [4] In some studies, cost is the amount of money a payer, such as Medicare or Blue Cross, pays for health care. In other studies, costs might represent the amount of resources a geographically based population uses on health care, such as how much money is expended on health care in California.
Rarely discussed is how much it costs for a hospital to provide care for an individual patient with a specific problem, such as a patient undergoing a cholecystectomyd what herein will be referred to as hospital costs. Hospital costs are the sum of the hospital's expenditures in caring for the patient. This can be derived in at least 2 ways. One is directly through the hospital's accounting database. 5, 6 This is done by calculating individual patient costs based on the itemized clinical care activity recorded for each patient in the database. In addition, costs for hospital infrastructure such as administration, billing, and electricity are included. However, because access to these data is usually available only to personnel within the hospital organization, studies based on accounting databases have typically been limited to single hospitals or hospital systems. A second way to estimate hospital costs is to convert patient charges reported in publicly available Medicare claims data to costs using hospital cost-to-charge ratios. [7] [8] [9] [10] [11] [12] This method has the substantial advantage that it can be used to determine the hospital costs for patients cared for in diverse hospitals. These individual patient costs can be disaggregated into cost centers. 9 There were 3 aims for this work. The first was to describe the distribution and magnitude of costs a hospital incurs to care for patients with 1 of 3 common surgical conditions, in aggregate and by cost center. The second was to examine whether costs varied with length of stay, operating room time, patient case-mix severity, and other patient comorbidities (measured using ACS-NSQIP data), as was anticipated from clinical experience. The third was to assess the extent to which there was significant residual variation in hospital cost after risk adjusting for patient case-mix severity, comorbidities, and procedure type.
METHODS

Data sources and measures
Three data sources were used: a clinical data source, an administrative data source, and Medicare cost reports. The clinical data source was the American College of Surgeons' National Surgical Quality Improvement Program (ACS-NSQIP). The ACS-NSQIP is a voluntary clinical registry that uses dedicated full-time trained surgical clinical reviewers who use strict data definitions to collect preoperative demographic and comorbidity patient variables, procedural, and postoperative 30-day patient outcomes data. Regular audits of a sample of hospitals are performed to ensure accuracy of data collection. This clinical dataset was merged with an administrative dataset, the Medicare Provider Analysis and Review File (Medpar), from 2005 to 2008, using indirect patient identifiers and a deterministic linkage algorithm, previously described. 13 The data elements in this file included demographics (sex, race or ethnicity, and age), dates of admission and discharge, ICD-9 diagnosis codes, ICD-9 procedure codes, and disaggregated cost-center charges. The third data source was the Medicare cost reports that are an annual compilation of all hospitals' reported costs and charges by cost centers. These data can be used to generate a cost-to-charge ratio for each cost center for each hospital for each fiscal year. These hospital, fiscal year, cost center-specific cost-to-charge ratios were merged with the Medicare claims data and used to estimate hospital costs from patient disaggregated costcenter charges in the Medicare inpatient claims file.
Primary outcome
The primary outcome was the estimated cost of the inpatient surgical hospitalization from the hospital's perspective. The claims data in the Medicare inpatient claims data file contain the disaggregated patient charges in 32 cost centers. Hospitals annually report all of their costs and charges by 44 cost centers to Medicare. These publicly available cost and charge data (by 44 cost centers) were aggregated into 12 discrete cost centers, as has been done in previous work (Appendix 1, online only), and were used to generate cost-to-charge ratios for each cost center for each hospital for each fiscal year. Extreme, unfeasible outliers in the cost-to-charge ratios were observed, as have been previously reported. 9 Cost-tocharge ratios within each of the 12 cost centers were therefore pulled in (winsorized) to the 2.5 and 96 percentiles, as previously done with these data. 9 These hospital, fiscal year, cost center-specific cost-to-charge ratios were merged with the Medicare claims data and used to estimate hospital costs from disaggregated patient charges in the Medicare inpatient claims file. All costs were inflated to 2013 dollars using the Medicare Market Basket Index. Regional differences in wage rates were adjusted for using the regional wage index. Finally, all patient costs at the cost center level were winsorized to the 0.25 percentile and the 99.75 percentile cost, to minimize the influence of extreme cost outliers.
Hospital cost allocation to cost centers was then examined by calculating the proportion of total annual hospital costs allocated to 5 of 12 of the largest cost centers: intensive care, operating room, supply, pharmacy, and laboratory. Although the variation in proportion of total annual hospital costs depended on the cost center, the interquartile ranges (IQR) were fairly narrow. A median of 5% of total hospital annual costs were attributed to intensive care, with a narrow IQR of 4% to 6%. A median of 10% of total hospital annual costs were attributed to operating room, with an IQR of 8% to 14%. A median of 8% 
Statistical analysis
Descriptive statistics of patient case-mix severity measures, comorbidities, and costs were performed. In this analysis, case-mix severity is used to describe American Society of Anesthesiologists (ASA) class and functional status, 2 ordinal scoring systems that attempt to capture the general gestalt picture of a patient's overall health. The descriptive statistics included counts and frequencies for patient case-mix severity and comorbidities. Median and IQR were calculated for the duration of care in terms of length of stay and operative time for each operation type. Median and IQR total costs, and for individual cost centers, were calculated for each of the 3 operations.
The correlations of cost center costs (room and board and operating room) with established measures of duration of care (length of stay and operative time) were determined using the Spearman correlation. The associations between cost and patient case-mix severity, comorbidities, and procedure type were determined using multivariable regression. Initial bivariate ordinary least squares regressions were run for each of the patient characteristics, case-mix severity, and comorbidities captured in ACS-NSQIP against log-transformed hospital cost. The CPT code variable was created as a single nominal categorical variable with laparoscopic cholecystectomy serving as the reference category for the other procedures and was used to estimate the influence of procedure type on cost. All patient and procedural variables significantly associated with log-transformed hospital cost on bivariate regressions were included in multivariable ordinary least squares regression using stepwise selection to identify variables associated with log-transformed hospital costs. The R 2 of this model assessed how much variance the model explained. In total, 21 variables (sex, age, functional status, ASA classification, previous surgery within 30 days, open wound at time of surgery, greater than 10% body weight loss in previous 6 months before surgery, CPT code, wound classification, COPD, preoperative ventilator use, preoperative dialysis use, ascites, hypertension, myocardial infarction, congestive heart failure, cancer, steroid use preoperatively, bleeding disorder, preoperative transfusion, and preoperative sepsis) selected were included in a mixed effects multivariate gamma regression to obtain precise estimates of how each variable was associated with cost (with a strongly right skewed distribution), while adjusting for hospital level clustering using a random intercept.
Hospital variation in risk-adjusted cost was examined by calculating the hospital cost ratio as the exponentiated best linear unbiased predictor of the hospitals (random) intercept, with 95% confidence intervals. This value will be referred to as the (risk-adjusted) hospital cost ratio estimate. The hospital cost ratio estimate is interpreted as the ratio of that hospital's costs over the average hospital's costs with equivalent patient case-mix severity, comorbidities, and procedure type. Confidence intervals for these hospital cost ratio estimates were sorted from lowest to highest point estimate into a caterpillar plot. If the lower 95% confidence limit was greater than 1, then the hospital had significantly higher costs than the "average", or grand mean of all, hospitals in this analysis. If the upper 95% confidence limit was less than 1, then the hospital had significantly lower costs than the grand mean of all hospitals in the analysis. It should be reinforced that the cost ratio estimate quantifies how hospitals performed with respect to the grand mean of all hospitals in the analysis, not with respect to one another.
In order to further qualify variation in cost based on hospital setting, patient costs were compared across core-based statistical areas (CBSA). Initial nonparametric bivariate comparisons (Kruskal-Wallis tests) were done to determine whether unadjusted costs varied among division metropolitan, metropolitan, micropolitan, and rural CBSAs. An adjusted comparison was then performed using the same mixed effects multivariate gamma regression described above, including CBSA type and comparing the adjusted change in cost among CBSAs. Last, to further explain some of the variation in patient cost of surgical care, patient costs were compared among patients who had no complications, patients who had at least one morbidity, and patients who had a mortality. Nonparametric bivariate comparisons (Kruskal-Wallis test) were done to determine whether unadjusted costs varied among patients who had no complications, those who had at least one morbidity, and those who had a mortality. The RAND Corporation institutional review board approved this study. All data management and analyses were performed in SAS 9.3.
RESULTS
A total of 21,923 patients from 202 hospitals were determined to have undergone 1 of the 3 most common abdominal operations. Colectomies were the most common abdominal procedures, accounting for 64% of patients (Table 1) . Of the 21,923 patients, the largest proportion of patients, 44%, were between the ages of 65 and 75, 44% were male, 2% of patients had congestive heart failure preoperatively, and 9% had COPD. Most patients (58%) had an ASA class of III, and 7% of patients had lost more than 10% of their body weight in the 6 months preceding surgery.
Patients' median length of stay was 7 days, with an IQR difference of 8 days. The median length of stay varied with the type of abdominal surgery, from 5 days for a cholecystectomy (IQR difference, 5 days), 7 days for a colectomy (IQR difference, 5 days), and 9 days for a pancreatectomy (IQR difference, 8 days). Median operative time was 120 minutes for all operations (IQR difference, 99 minutes), but ranged from a median of 83 minutes (IQR difference, 61 minutes) for a cholecystectomy, 137 minutes (IQR difference, 88 minutes) for a colectomy, to 335 minutes (IQR difference, 160 minutes) for a pancreatectomy.
Total costs varied among the different abdominal operations. The median total cost of care ranged from $15,651 (IQR, $9,923 to $25,289) for cholecystectomy, to $37,745 (IQR, $28,193 to $57,213) for a pancreatectomy (Table 2) . Patient room and board costs accounted for the largest proportion of total patient costs, accounting for 50% of costs in colectomy patients and 46% of costs in both cholecystectomy and pancreatectomy patients. The median room and board cost among all abdominal operations was $10,747 (IQR, $6,496 to $18,255). Median room and board costs ranged from $7,232 (IQR, $3,859 to $12,791) for cholecystectomy to $17,250 (IQR, $11,651 to $28,332) for pancreatectomy. Room and board costs were highly correlated with length of stay (R ¼ 0.89, p < 0.0001). Operating room costs accounted for the next highest proportion of (Table 3) . Patient case-mix severity variables associated with greater than a 1.5-fold increase in adjusted hospital cost included being partially dependent (estimate, 1.50, 95% CI 1.46 to 1.55) or fully dependent (estimate, 1.63, 95% CI 1.53 to 1.74) in comparison with being independent preoperatively; and ASA class IV (estimate, 1.72, 95% CI 1.57 to 1.87) or ASA class V (estimate, 1.53, 95% CI 1.18 to 1.98) in comparison with ASA class I. There were 3 procedure types associated with a 3-fold or greater increase in adjusted cost in comparison with laparoscopic cholecystectomy; cholecystectomy with stone extraction (estimate, 4.24, 95% CI 1.36 to 13.19), partial removal of pancreas (estimate, 3.65, 95% CI 3.50 to 3.82), and pancreatectomy (estimate, 3.33, 95% CI 3.17 to 3.49). The total variance explained by the model detailed in Table 3 was 37%.
After risk-adjustment for patient case-mix severity, comorbidities, and procedure type, there was still substantial variation in cost among hospitals (Fig. 1) . Of the 202 hospitals, 79 were classified as "average" cost hospitals, meaning that costs were not statistically significantly different from the grand mean of hospitals in the analysis after controlling for patient case-mix severity, comorbidities, and procedure type. Median hospital cost of care was $26,285. Sixty-six hospitals had significantly lower costs than the average hospital with comparable patients and procedure types. Median hospital cost of care was $34,556 at high outlier hospitals. Fifty-seven hospitals had significantly higher costs than the average hospitals with comparable patients and procedure types. Median hospital cost of care at low outlier hospitals was $21,081.
To further determine what underlay variation in cost among hospitals, a subanalysis of cost by hospitals setting was performed. There was significant variation in the unadjusted cost by hospital setting across all cost centers ( Table 4 ). The median total cost for patients in division metropolitan areas was $24,090 (IQR, $15,648 to $39,826). The median cost for patients in metropolitan areas was $21,365 (IQR, $14,281 to $34,460). The median cost for patients in micropolitan areas was $15,161 (IQR, $10,945 to $23,604). The median cost of patients in rural areas was $15,901 (IQR, $11,970 to $24,112). After adjusting for regional wage index, patient case-mix severity and comorbidities, and procedure, hospitals in division metropolitan areas had 1.23 times higher total adjusted costs than hospitals in simple metropolitan areas (95% CI 1.11 to 1.37) and 1.58 times higher total adjusted costs than micropolitan areas (95% CI 1.21 to 2.06).
Lastly, the average morbidity and mortality rates were 22.8% (n ¼ 4,993) and 3.1% (n ¼ 673), respectively. When the unadjusted costs were compared among patients who did not have complications with those who had at least one morbidity and those who had mortality, there was significant variation across all cost centers ( Table 5 ). The median total cost for patients without complications was $19,375 (IQR, $13,349 to $29,280). The median total cost for patients with at least one morbidity was $37,033 (IQR, $22,418 to $65,674). The median cost for patients with mortality was $50,465 (IQR, $29,657 to $86,221).
DISCUSSION
This study determined the median cost for an inpatient elective colectomy, cholecystectomy, and pancreatectomy to be $22,193, $15,651, and $37,745, respectively. These estimates are comparable to those in previous studies. [14] [15] [16] Furthermore, this study found that room and board costs accounted for nearly half of all costs and were highly correlated with length of stay. Similarly, operating room time was associated with operating room costs. In addition, multivariate analysis demonstrated that patient case-mix severity, comorbidities, and procedure type were correlated in expected ways with hospital costs. The relationship between the hospital costs and the duration of clinical care, the invasiveness of procedures, and the patient case-mix severity reinforces the soundness of this cost estimate. These data suggest that it is feasible to use Medicare cost-to-charge ratio data to obtain reasonable estimates of patient hospital costs at the cost center level. Not only does the cost estimate seem consistent with clinical expectations but there also seems to be Figure 1 . Risk-adjusted hospital cost ratios for elective abdominal operations. Adjusted for procedure type and patient case-mix severity and comorbidities that were present on admission. Hospitals with confidence limits depicted in red had adjusted costs higher than the average hospital. Hospitals with confidence limits depicted in green had adjusted costs lower than the average hospital. 9 Understanding what services fall into each cost center may further help hospitals focus efforts on identifying low value expenditures that can be reduced.
Although both cost and payment can be used to evaluate the economics of surgical care, there is a distinct advantage to using cost data. Payments are the more traditional cost metric in the literature and, unlike hospital costs, typically include hospital profits. Studies that have studied both payments and hospital costs have demonstrated that there is a strong correlation between the two, with payments being about 20% higher than hospital costs in normal situations, though this varies by payer. 5, 17 However, the difference in payments and hospital costs decreases when a complication occurs, 17 and the magnitude of this decrease varies by the nature of payment (per discharge, per diem, proportion of charges) and payer type. 5 Payments are complex and are influenced by many variables other than how efficiently a hospital produces care. 18 As such, payments may be less helpful to hospitals as a feedback metric if the goal is to improve how efficiently hospitals provide care. Correctly estimating the cost of production of hospital care may help providers and policy makers design mechanisms to improve the value of surgical care while maintaining quality for all patients regardless of payer.
There are several limitations to this work. First, the external generalizability of this study is limited because this patient sample was exclusively Medicare patients 65 years and older seeking inpatient care at ACS-NSQIP hospitals. The ACS-NSQIP hospitals are known to be biased toward large academic centers and therefore may not be representative of the hospital population at large. Furthermore, because this study was limited to inpatient records, it captured patients with a higher comorbidity burden and likely more serious surgical disease. This can be seen by the relatively long median length of stay (5 days) for an inpatient cholecystectomy. Second, professional fees were not included in this analysis. As a result, the full cost of care was underestimated. Third, the cost estimates are dependent on the existing publicly available Medicare cost-to-charge ratios. Hospitals may not accurately report the actual annual charges and costs of patient care. Cost-to-charge ratios rely on hospitals' internal cost accounting data, for which there is wide variability across institutions, and may not represent the actual cost of the delivered service. Although extensive data vetting procedures in accordance with established norms 9 were used in handling these data, it is possible that inaccuracies in these data may have led to misrepresentations of the hospital cost of the production of care. Additionally, certain indirect costs are deliberately factored into varying cost centers, often the daily rate for room and board, and cannot be further separated. 19 Finally, the timeliness of the MedPar and cost-to-charge ratio data is a concern because of the significant focus and emphasis on these data over the past 5 years. Future directions include obtaining more contemporaneous data to understand recent trends in cost of surgical care.
CONCLUSIONS
This article identified the hospital costs derived from charges for 3 common elective abdominal operations among 202 hospitals. These cost estimates vary, as might be expected, by the type of abdominal surgery performed, duration of care, and patient case-mix severity and comorbidities. Furthermore, even after accounting for patient case-mix severity, comorbidities, and procedure type, there is significant variation in hospitals costs. Hopefully, these data can be used to encourage cooperation among hospitals so that the value of surgical care can be improved without sacrificing quality.
